🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Li Chen

Northwestern University

ORCID: 0000-0001-9303-4047

Also affiliated with Harvard University, University of the Basque Country, Canberra Hospital, Massachusetts General Hospital, Northwestern University, Frederick National Laboratory for Cancer Research, Northwestern Medicine, Center for Cancer Research, Flatiron Health (United States), Neurological Surgery, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
2.8Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3
Top 8%
2.7DataRank
Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

Papers

Driven by 8 papers — median percentile 22. Top paper: “Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment”.

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3
Top 8%
2.7DataRank
Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts

Nature Genetics(2021)10.1038/s41588-020-00750-6
N/A
0.790DataRank · unranked
193 citations

Jessica Giordano, Anuj Srivastava, Min Jin Ha, Michael W. Lloyd, Roebi de Bruijn +57 more

MEScan: a powerful statistical framework for genome-scale mutual exclusivity analysis of cancer mutations

Bioinformatics(2020)10.1093/bioinformatics/btaa957
N/A
0.425DataRank · unranked
16 citations

Jinpeng Liu, Yanqi Xie, Tingting Zhai, Eugene W. Hinderer, Arnold J. Stromberg +7 more

A Probabilistic Approach to Estimate the Temporal Order of Pathway Mutations Accounting for Intra-Tumor Heterogeneity

Research Square(2024)10.21203/rs.3.rs-3833734/v1
N/A
0.110DataRank · unranked
1 citations

Yanqi Xie, Jinpeng Liu, Austin Li, Li Chen, Arnold J. Stromberg +3 more

Blood-based assessment of patients with mismatch repair-deficient tumors enrolled in NCI-MATCH Arm Z1D (nivolumab).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2560
Top 78%
0.104DataRank
Top 78%1 citations

Jennifer L. Silhavy, Jennifer S. LoCoco, Biswajit Das, Sorena Rahmanian, Ting-Chia Chang +15 more

Genomic characterization of preclinical models derived from primary and metastatic sites from rapid autopsy patients in PDMR.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e13506
Top 100%
0DataRank
Top 100%0 citations

Rajesh Patidar, Biswajit Das, Yvonne A. Evrard, Chris Karlovich, Tomas Vilimas +15 more

Tumor genomic analysis for biomarker identification in a phase I trial of the Wee 1 inhibitor adavosertib (AZD1775).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3624
N/A
0DataRank · unranked
4 citations

Arjun Mittra, Geraldine O’Sullivan Coyne, Li Chen, Biswajit Das, Shivaani Kummar +15 more

Blood-based detection of actionable alterations from NCI-MATCH patients with no tissue results.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3035
N/A
0DataRank · unranked
0 citations

Amanda Peach, D. A. HOWELL, Biswajit Das, Rini Pauly, Ting-Chia Chang +14 more